Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-18 2:42 pm Unchanged | 2020-11-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,765,717 7.800% | 0 (Unchanged) | Filing History |
| 2020-11-05 08:53 am Sale | 2020-11-04 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Topspin Fund L.P. | 1,100,446 3.670% | -2,212,178 (-66.78%) | Filing History |
| 2020-05-11 08:45 am Purchase | 2020-05-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 3,237,333 10.820% | 3,237,333 (New Position) | Filing History |
| 2020-05-01 5:29 pm Purchase | 2020-04-24 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital, LLC | 2,642,218 8.800% | 2,642,218 (New Position) | Filing History |
| 2020-05-01 4:15 pm Purchase | 2020-04-28 | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,765,717 9.200% | 2,765,717 (New Position) | Filing History |
| 2020-04-28 7:51 pm Purchase | 2020-04-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Topspin Fund L.P. | 3,312,624 11.510% | 3,312,624 (New Position) | Filing History |